Testing for residual leukemia
April 03, 2026
April 03, 2026
ROANOKE, Virginia, April 3 -- The Fralin Biomedical Research Institute at Virginia Tech posted the following news:
* * *
Testing for residual leukemia
*
This year, 22,000 Americans will be diagnosed with acute myeloid leukemia, an aggressive blood cancer.
Many respond well to chemotherapy and appear to achieve complete remission. But even when standard tests indicate that the cancer has cleared, not all of these patients will surv . . .
* * *
Testing for residual leukemia
*
This year, 22,000 Americans will be diagnosed with acute myeloid leukemia, an aggressive blood cancer.
Many respond well to chemotherapy and appear to achieve complete remission. But even when standard tests indicate that the cancer has cleared, not all of these patients will surv . . .